An Open-Label, Randomized, Five-Period Cross-over, Single-dose Study to Compare Pharmacokinetics Profiles of Z7200 Midium Strength and Symbicort Turbohaler, With and Without Charcoal Blockade in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 05 Oct 2016
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Zambon Company SpA
- 11 Jul 2016 Status changed from not yet recruiting to completed.
- 18 Dec 2015 New trial record